Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-16-153591
Filing Date
2016-11-01
Accepted
2016-11-01 12:04:58
Documents
5
Period of Report
2016-11-01

Document Format Files

Seq Description Document Type Size
1 6-K a16-19793_76k.htm 6-K 18756
2 EX-99.1 a16-19793_7ex99d1.htm EX-99.1 11478
3 EX-99.2 a16-19793_7ex99d2.htm EX-99.2 16279
4 GRAPHIC g197937mmi001.jpg GRAPHIC 3364
5 GRAPHIC g197937mmi002.gif GRAPHIC 2370
  Complete submission text file 0001104659-16-153591.txt   55872
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1 843-900-3211
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-30752 | Film No.: 161963825
SIC: 2834 Pharmaceutical Preparations